EP3947375
Imídasólónýlkínólín-efnasambönd og meðferðarnotkun á þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
25.3.2020EP published:
3.4.2024EP application number:
20715020.2
EP translation filed:
3.6.2024Grant published:
15.7.2024EPO information:
European Patent Register
Max expiry date:
24.3.2040Expiry date:
24.3.2027Next due date:
31.3.2027
Title in English:
IMIDAZOLONYLQUINOLINE COMPOUNDS AND THERAPEUTIC USES THEREOFLanguage of the patent:
English
Timeline
Today
25.3.2020EP application
3.4.2024EP Publication
3.6.2024Translation submitted
15.7.2024Registration published
24.3.2027Expires
Owner
Name:
Merck Patent GmbHAddress:
Frankfurter Strasse 250, 64293 Darmstadt, DE
Inventor
Name:
FUCHSS, ThomasAddress:
64625 BENSHEIM-AUERBACH, DE
Name:
BECKER, AxelAddress:
64342 SEEHEIM-JUGENHEIM, DE
Name:
KUBAS, HolgerAddress:
61352 Bad Homburg, DE
Name:
GRAEDLER, UlrichAddress:
69469 Weinheim, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
19165664Date:
27.3.2019Country:
EP
Classification
Categories:
C07D 471/04, A61P 35/00, A61K 31/4375
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 14.2.2025
Expires: 24.3.2026
Payer: Árnason Faktor ehf.
Number: 7
Paid: 20.3.2026
Expires: 24.3.2027
Payer: Árnason Faktor ehf.